持续实施多组分策略以增加急诊科启动的阿片类使用障碍干预
该研究在3家城市学术型急诊科回顾性分析电子健康记录,纳入2017年3月至2020年7月成人阿片类使用障碍相关就诊,比较实施多组分策略前后(2018年12月为界)的丁丙诺啡使用及流程指标。共2,665次相关就诊,28%为过量、8%为戒断、64%为其他情况;总体13%的患者在急诊就诊期间或之后接受了阿片类使用障碍药物治疗。实施后丁丙诺啡总量净增加20%(95%CI 16%–23%),调整患者水平模型显示实施时丁丙诺啡治疗概率立即增加24.5%(95%CI 12.1%–37.0%)。70%的医生至少开出1张丁丙诺啡处方,但医生层面处方率范围为0%–61%。作者认为策略与治疗及流程指标的持续增加相关,但医生采纳差异大,需要额外策略扩大应用。
要点
- 在3家城市学术型急诊科实施多组分策略后,丁丙诺啡治疗概率立即增加24.5%(95%CI 12.1%–37.0%)。
- 实施后丁丙诺啡总量净增加20%(95%CI 16%–23%),治疗和流程指标呈持续增加。
- 研究期间2,665次阿片类使用障碍相关就诊中,28%为过量、8%为戒断、64%为其他情况。
- 总体13%的患者在急诊就诊期间或之后接受了阿片类使用障碍药物治疗。
- 70%的医生至少开出1张丁丙诺啡处方,但医生层面处方率范围为0%–61%,作者认为需要额外策略扩大采纳。
适用人群与场景
- 3家城市学术型急诊科中成人阿片类使用障碍相关就诊患者,就诊时间在2017年3月至2020年7月之间。
研究设计与关键结果
- 研究类型为回顾性电子健康记录数据分析,比较实施前(2017年3月至2018年11月)与实施后(2018年12月至2020年7月)的情况。
- 共纳入2,665次阿片类使用障碍相关就诊:28%为过量、8%为戒断、64%为其他情况。
- 总体13%的患者在急诊就诊期间或之后接受了阿片类使用障碍药物治疗。
- 实施后丁丙诺啡总量净增加20%(95%CI 16%–23%),治疗和流程指标持续增加。
- 调整患者水平多变量logistic回归模型显示,实施时丁丙诺啡治疗概率立即增加24.5%(95%CI 12.1%–37.0%)。
- 70%的医生至少开出1张丁丙诺啡处方,但医生层面丁丙诺啡处方率范围为0%–61%。
证据类型、等级与局限
- 证据类型:回顾性电子健康记录数据分析,采用中断时间序列分析和患者水平多变量logistic回归模型。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,增加急诊科启动阿片类使用障碍治疗的多组分策略组合与治疗及流程指标的持续增加相关;但医生采纳差异大,提示需要额外策略扩大应用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: There is strong evidence supporting emergency department (ED)-initiated buprenorphine for opioid use disorder, but less is known about how to implement this practice. Our aim was to describe implementation, maintenance, and provider adoption of a multicomponent strategy for opioid use disorder treatment in 3 urban, academic EDs.
METHODS: We conducted a retrospective analysis of electronic health record data for adult patients with opioid use disorder-related visits before (March 2017 to November 2018) and after (December 2018 to July 2020) implementation. We describe patient characteristics, clinical treatment, and process measures over time and conducted an interrupted time series analysis using a patient-level multivariable logistic regression model to assess the association of the interventions with buprenorphine use and other outcomes. Finally, we report provider-level variation in prescribing after implementation.
RESULTS: There were 2,665 opioid use disorder-related visits during the study period: 28% for overdose, 8% for withdrawal, and 64% for other conditions. Thirteen percent of patients received medications for opioid use disorder during or after their ED visit overall. Following intervention implementation, there were sustained increases in treatment and process measures, with a net increase in total buprenorphine of 20% in the postperiod (95% confidence interval 16% to 23%). In the adjusted patient-level model, there was an immediate increase in the probability of buprenorphine treatment of 24.5% (95% confidence interval 12.1% to 37.0%) with intervention implementation. Seventy percent of providers wrote at least 1 buprenorphine prescription, but provider-level buprenorphine prescribing ranged from 0% to 61% of opioid use disorder-related encounters.
CONCLUSION: A combination of strategies to increase ED-initiated opioid use disorder treatment was associated with sustained increases in treatment and process measures. However, adoption varied widely among providers, suggesting that additional strategies are needed for broader uptake.
参考来源
- Lowenstein M, Perrone J, Xiong RA, et al. Sustained Implementation of a Multicomponent Strategy to Increase Emergency Department-Initiated Interventions for Opioid Use Disorder. Ann Emerg Med. 2021. PMID: 34922776. doi:10.1016/j.annemergmed.2021.10.012
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。